Enteric fever, primarily caused by Salmonella Typhi and Paratyphi, remains a significant global health issue. Despite advancements in diagnostic tools and therapeutic strategies, challenges persist in clinical practice. This article aims to provide an updated approach to the diagnosis and management of enteric fever.
Accurate diagnosis of enteric fever is critical. Traditional methods, such as blood culture, remain the gold standard but suffer from sensitivity issues. Recent advances in molecular diagnostics, including PCR-based tests, offer improved sensitivity and specificity. Serological tests like Widal and Typhidot are commonly used in resource-limited settings, but their reliability is questionable due to cross-reactivity and variability in antibody response. Therefore, integrating these methods with clinical suspicion and epidemiological data is crucial.
Antimicrobial therapy is the cornerstone of enteric fever management. Resistance to first-line drugs, such as chloramphenicol, ampicillin, and trimethoprim-sulfamethoxazole, has led to the use of fluoroquinolones. However, the emergence of fluoroquinolone-resistant strains necessitates alternative therapies. Third-generation cephalosporins and azithromycin have shown promising results. The choice of antimicrobial should be guided by local susceptibility patterns and patient characteristics.
Supportive care, including hydration and symptom management, is crucial. Vaccination remains the most effective preventive measure. Currently, two vaccines (Ty21a and Vi polysaccharide) are available, but their protective efficacy varies. Improved sanitation and safe food practices are also essential in preventing enteric fever.
Enteric fever continues to pose significant challenges due to diagnostic limitations and antimicrobial resistance. An integrated approach, encompassing accurate diagnosis, appropriate antimicrobial therapy, supportive care, and preventive measures, is crucial. Further research is needed to develop more effective diagnostic tools, therapeutic strategies, and vaccines to combat this persistent global health threat.
1.
Can Prior Authorization Be Better With Artificial Intelligence?
2.
How a California Oncologist Making $850k Spends Money
3.
DNA's hidden shape reveals target to reverse ovarian cancer chemoresistance
4.
Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.
5.
Because of the Medicare mail-order drug rule, oncologists run the risk of self-referral violations.
1.
Unveiling the Hidden Dangers of Hand Cancer: How to Protect Yourself
2.
Uncovering the Mysteries of Breast Cancer: The Journey to a Cure
3.
Erythropoiesis Modulation in Chronic Anemia Management
4.
Comprehensive Concepts in Oncology in Clinical Decision-Making
5.
Precision Cancer Risk Mitigation Strategies
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
2.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
3.
Managing Supportive Care During Platelet Recovery
4.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
5.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation